Details for 2019718531

Up to date per 01.04.2026

Actions

Title / Product Name

RET-INHIBITOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS MIT EINER RET-VERÄNDERUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019718531

EP Publication Number

3773589

E-Number

1626438

Language

PCT Number

US19025655

Publication Date

17.02.2021 A

01.11.2023 B1

Registration Date

01.11.2023

AT Publication Date

15.11.2023

Application Date

03.04.2019

Registration Number

Priorities

03.04.2018

201862652284 P

11.04.2018

201862656297 P

13.04.2018

201862657605 P

05.10.2018

201862741683 P

IPC

A61K 31/506 20060101AFI20191011BHEP

Maximum Duration of Protection

03.04.2039

Owner

Blueprint Medicines Corporation45 Sidney Street Cambridge, MA 02139US

Representative

No representatives present

Inventor

EVANS RAAB, Erica45 Sidney Street Cambridge, Massachusetts 02139US

WOLF, Beni B.45 Sidney Street Cambridge, Massachusetts 02139US

Information about Fees